Russell Investments Group
SRNE

Russell Investments Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Russell Investments Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-266
Closed -$25 – 3368
2023
Q3 		$25 Hold
266
– – ﹤0.01% 3513
2023
Q2 		$95 Hold
266
– – ﹤0.01% 3435
2023
Q1 		$96 Buy
+266
New +$238 ﹤0.01% 3274
2022
Q1 		– Sell
-3,200
Closed -$14K – 3006
2021
Q4 		$14K Hold
3,200
– – ﹤0.01% 2969
2021
Q3 		$24K Buy
+3,200
New +$27.1K ﹤0.01% 2990
2021
Q2 		– Sell
-56,482
Closed -$467K – 3337
2021
Q1 		$467K Hold
56,482
– – ﹤0.01% 2551
2020
Q4 		$385K Buy
+56,482
New +$454K ﹤0.01% 2534
2019
Q1 		– Sell
-106,819
Closed -$256K – 3051
2018
Q4 		$256K Sell
106,819
-96,768
-48% -$316K ﹤0.01% 2536
2018
Q3 		$896K Buy
+203,587
New +$1.13M ﹤0.01% 2157
2018
Q2 		– Sell
-5,915
Closed -$30K – 2987
2018
Q1 		$30K Buy
+5,915
New +$42.1K ﹤0.01% 2860
2017
Q2 		– Sell
-20,423
Closed -$81K – 3069
2017
Q1 		$81K Buy
20,423
+6,699
+49% +$33.6K ﹤0.01% 2844
2016
Q4 		$69K Buy
+13,724
New +$82.4K ﹤0.01% 2937

Other funds holding SRNE

LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

Russell Investments Group's SRNE Position: Q4 2023 in Review

Russell Investments Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2023, closing a stake of 266 shares — an estimated $25 sold.

Russell Investments Group first reported a position in SRNE in Q4 2016 and held it in 12 quarters. The position peaked at $896K in Q3 2018. 9 funds tracked by Wall St. Rank hold SRNE as of Q4 2023.

  • Russell Investments Group reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
  • Russell Investments Group sold 266 Sorrento Therapeutics, Inc. shares in Q4 2023, an estimated $25.
  • Russell Investments Group first reported a position in Sorrento Therapeutics, Inc. in Q4 2016 and held it in 12 quarters.
  • Russell Investments Group's Sorrento Therapeutics, Inc. position peaked at $896K in Q3 2018.
  • 9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2023.

Based on Russell Investments Group's 13F filing for Q4 2023, filed 5 Feb 2024.